Marshall Wace’s 1Life Healthcare ONEM Stock Holding History

Marshall Wace’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-159,798	Closed	-$2.67M	–	3487
2022 Q4	$2.67M	Buy	159,798 +87,457	+121%	+$1.48M	0.01%	1568
2022 Q3	$1.24M	Buy	+72,341	New	+$1.14M	﹤0.01%	2298
2022 Q1	–	Sell	-18,926	Closed	-$332K	–	4299
2021 Q4	$332K	Sell	18,926 -167,582	-90%	-$3.25M	﹤0.01%	2990
2021 Q3	$3.78M	Buy	186,508 +175,325	+1,568%	+$4.51M	0.02%	1119
2021 Q2	$370K	Buy	+11,183	New	+$422K	﹤0.01%	2255

Marshall Wace's ONEM Position: Q1 2023 in Review

Marshall Wace sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 159,798 shares — an estimated $2.67M sold.

Marshall Wace first reported a position in ONEM in Q2 2021 and held it in 5 quarters. The position peaked at $3.78M in Q3 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Marshall Wace reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 159,798 1Life Healthcare shares in Q1 2023, an estimated $2.67M.
Marshall Wace first reported a position in 1Life Healthcare in Q2 2021 and held it in 5 quarters.
Marshall Wace's 1Life Healthcare position peaked at $3.78M in Q3 2021.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.